Smartkarma Daily Briefs

We analyzed the changes in short interest of Stock Exchange of Thailand as of Mar 7th.We estimate that they had an aggregated short interest worth USD2.0bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
We highlight short interest changes in Bangkok Dusit Medical Services, WHA, Airports of Thailand, PTT GlobalChem, Thai Oil, Delta Electronics.

KRX Foreign Holding Weekly (Mar 7th): Samsung Electronics, SK Hynix, Samsung H.I.

We analyzed the changes in foreign holdings of KRX stocks as of Mar 7th which has an aggregated holding worth USD479.8bn.
We estimate that foreign flows to be outflows of USD1,400mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
We highlight changes of foreign holdings in Samsung Electronics, SK Hynix, Samsung H.I..

TWSE Foreign Holding Weekly (Mar 7th): Jinan Acetate Chemical, TSMC, Mediatek

We analyzed the changes in foreign holdings of TWSE Stocks as of Mar 7th which has an aggregated holding worth USD963.2bn.
We estimate that foreign flows to be outflows of USD5,430mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
We highlight changes of foreign holdings in Jinan Acetate Chemical, TSMC, Mediatek, Hon Hai Precision Industry, Delta Electronics, Quanta Computer.

TWSE Short Interest Weekly (Mar 7th): Chung-Hsin Electric & Machinery Mfg, Wiwynn, Formosa Plastics

We analyzed the changes in short interest of TWSE Stocks as of Mar 7th which has an aggregated short interest worth USD21.2bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
We highlight short interest changes in Chung-Hsin Electric & Machinery Mfg, Wiwynn, Formosa Plastics, Walsin Lihwa, Nanya Technology, Global Unichip, China Steel.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief ESG: Significant Share Buybacks Are Key to Improving Profitability of Capital and more

By Smartkarma Daily Briefs | Daily Briefs, ESG

In today’s briefing:

Significant Share Buybacks Are Key to Improving Profitability of Capital

Significant Share Buybacks Are Key to Improving Profitability of Capital

By Aki Matsumoto

While the company’s attitude toward shareholder returns has been positive, the 11% dividend increase is not expected to reduce cash on hand by much.
In a condition where so much cash has accumulated, it’s not a bad idea to use DOE as a guide to avoid accumulating cash on hand above a certain level.
Since FY3/2025 profits will grow in non-manufacturers, which has relatively low profit margin, the overall profit margin of companies won’t increase. Therefore, unless assets are reduced significantly, ROE will soft.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief Thematic (Sector/Industry): Ohayo Japan | Friday’s Gains Mask a Week of Fragility and more

By Smartkarma Daily Briefs | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

Ohayo Japan | Friday’s Gains Mask a Week of Fragility
[Blue Lotus China New Consumer Weekly, 10/52] Smart Trump or Dumb Trump? Part II
Japan Morning Connection: US Dip Buying for Tech Should See Dip Buying in Japan to Start.
[Blue Lotus Non-US Internet Weekly, 10/52]: Manus Signals the Excitement of Innovation Has Sunk In

Ohayo Japan | Friday’s Gains Mask a Week of Fragility

By Mark Chadwick

US stocks rose Friday—Dow and S&P 500 up 0.5%, Nasdaq 0.7%—but a volatile week, jobs data, and Fed restraint signal persistent uncertainty.
The Nikkei 225 fell 0.7% amid a volatile week, hit by trade tensions, a strong yen, and tech losses, despite gains in industrial/defense stocks.
Inpex plans to increase crude oil and natural gas production by 30% over the next decade; ACT will hold a press conference to discuss proposed acquisition of Seven

[Blue Lotus China New Consumer Weekly, 10/52] Smart Trump or Dumb Trump? Part II

By Eric Wen

The just concluded Two Sessions contained little surprises but the market shrugged it off. Have animal spirits offset China’s structural economic issues?
China’s EV sector grew 38% YoY in the first two months of 2025, above our annual target of 30%. We stick to our bullish view. 2024 grew 41% YoY;
MINISO explored spin off of its toy chain business. We maintain SELL rating on deteriorating China business.

Japan Morning Connection: US Dip Buying for Tech Should See Dip Buying in Japan to Start.

By Andrew Jackson

Sandisk +9.7% on reports it will be hiking NAND prices by 10% in April. More to go for Kioxia and Kokusai Electric?
Allegro running out of oomph but I would keep adding Sanken despite the jump.
Nintendo -9.2% Friday on tariff concerns excessive ahead of upcoming Switch2 announcement in April.

[Blue Lotus Non-US Internet Weekly, 10/52]: Manus Signals the Excitement of Innovation Has Sunk In

By Ying Pan

Chinese startup Manus launched a virtual AI assistant which we believe pointed to an important direction of monetization but the product itself has room for improvement;
Douyin followed BABA to launch AI-based omni-channel-promotion ads tools. The recent trend in China Internet advertising has been AI-driven take rate increases;
NetEase’s <Where the Winds Meet> seems to be a winner above our expectations.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief ECM: MIXUE Group (2097.HK) – Updates on Performance Forecast and Valuation Outlook and more

By Smartkarma Daily Briefs | Daily Briefs, ECM

In today’s briefing:

MIXUE Group (2097.HK) – Updates on Performance Forecast and Valuation Outlook
British Land: Buy on Improving Industry Fundamentals
Chifeng Jilong A/H Trading – Weak Institutional Demand and Probably Close to Fair Value
ECM Weekly (10th Mar 2025) – BYD, Japan Post, Mixue, Sanhua, Chifeng, Nanshan, Goertek, Travel Food

MIXUE Group (2097.HK) – Updates on Performance Forecast and Valuation Outlook

By Xinyao (Criss) Wang

MIXUE’s IPO debut was stellar. the IPO pricing of HK$202.5/share was indeed conservative. MIXUE is able to obtain more valuation premium space after IPO from a relatively low IPO pricing.
However, concerns on future performance growth remains. Investors need to pay attention to the performance verification. Market sentiment is becoming “overheated”, and the pressure for short-term stock price corrections increases.
We updated our forecast for 2025-2027. If based on P/E of 20-25x, market value is HK$109.4-136.8 billion, HK$122.5-153.2 billion, HK$134.8-168.5 billion based on 2025, 2026 and 2027 net profit, respectively.

British Land: Buy on Improving Industry Fundamentals

By Jacob Cheng

British Land is an office and retail landlord in UK. Around 60% of its assets are campus/offices, with all assets located in UK
We think the underling retail and office market are showing solid recovery, which will support British Land key operating business
British Land also sees capital recycling as an important pillar, including dividend, balance sheet management, and M&As to drive shareholders’ returns

Chifeng Jilong A/H Trading – Weak Institutional Demand and Probably Close to Fair Value

By Nicholas Tan

Chifeng Jilong Gold Mining (600988 CH) , a gold mining company in China, raised around US$363m in its H-share listing in Hong Kong.
It operates six gold mines in Asia and Africa and has been listed on the Shenzhen Stock Exchange since 2004.
We have covered the company and deal background in our previous notes. In this note, we talk about the trading dynamics.

ECM Weekly (10th Mar 2025) – BYD, Japan Post, Mixue, Sanhua, Chifeng, Nanshan, Goertek, Travel Food

By Sumeet Singh

Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
On the IPO front, Mixue Group (2097 HK) provided some much needed relief to the HK tea chains, Seoul Guarantee Insurance (031210 KS) might not do the same this week.
On the placements front, BYD (1211 HK)‘s jumbo offering has been doing well, while Japan Post Bank (7182 JP) hasn’t been correcting much.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief Equity Bottom-Up: Daihatsu Diesel (6023) Buyback Tender Results Signal Overhang and Opportunity and more

By Smartkarma Daily Briefs | Daily Briefs, Equity Bottom-Up

In today’s briefing:

Daihatsu Diesel (6023) Buyback Tender Results Signal Overhang and Opportunity
Tech News This Week. Apple AI, TSMC, Korea’s Giga-Fund, Stargate
Jindal Steel & Power (JSP IN) – Cyclical Downturn Provides Attractive Entry Point
J&T Global Express H224 Results: Levers That Drove Earlier Improvement Are Losing Power
Halyk Bank (HSBK LI)
AviChina Industry (2357 HK): The Discount to Narrow
Hanmi Pharm (128940 KS): Corporate Value Enhancement Plan Targets W5 Trillion Revenue by 2033
Multi Bintang Indonesia (MLBI IJ): Steady FY24, 9% Yield and >80% ROCE

Daihatsu Diesel (6023) Buyback Tender Results Signal Overhang and Opportunity

In late January, Daihatsu Diesel Mfg (6023 JP) announced its once/former parent would sell all its shares; in part to a private company in the industry and a 20% buyback.
The buyback – a below-market own-share tender offer – was priced low enough to be a big win. Accretion added to that.
Buyback Tender Results and External Changes signal overhang and opportunity. Either way, it’s cheap, but good governance could make it even cheaper.

Tech News This Week. Apple AI, TSMC, Korea’s Giga-Fund, Stargate

By Nicolas Baratte

Apple’s AI struggle. Google’s Gemini has won? TSMC ex-Chairman is joining Micron’s board
SK Hynix out of image sensors. Korean Gvt launch US$100bn fund for strategic industries
Stargate first data center is under way. Close to 100k Nvidia GPU in 2026. Hon Hai makes the servers.

Jindal Steel & Power (JSP IN) – Cyclical Downturn Provides Attractive Entry Point

By Rahul Jain

Strong focus on capacity enhancement. Increasing steelmaking capacity by 65% over the next 3 years to 15.9mt.
Recent margin dip provides attractive entry point. Promoters/insiders have bought into recent decline in stock price
Attractive long-term play on rising domestic steel demand. Low debt levels at <1.4x EBITDA allows for steady capacity addition.

J&T Global Express H224 Results: Levers That Drove Earlier Improvement Are Losing Power

By Daniel Hellberg

H224 showed moderating top-line growth, but solid Y/Y improvement in EBITDA margin
However, the levers that drove margin improvement in 2024 appear to be losing power
Within China’s express and logistics segment, we find SF Holding to be far more attractive

Halyk Bank (HSBK LI)

By Michael Fritzell

Kazakhstan is a landlocked country right between Russia and China. It’s wealthier than most realize, with a great amount of natural resources such as oil & gas and uranium.
Thanks to resource extractions and favorable demographics, GDP per capita has grown rapidly.
One of the biggest beneficiaries of that growth has been Halyk Bank – the country’s leading commercial bank.

AviChina Industry (2357 HK): The Discount to Narrow

By Osbert Tang, CFA

The share price of AviChina Industry & Technology H (2357 HK) has picked up in Mar, and it will continue to chase the HSI and HSCEI, in our view.
At 54.1%, AviChina’s discount to its A-share holdings has narrowed 4.2pp YTD, but is still behind the 6.2pp contraction for overall H-A shares. There is more room to catch up.
The increase in defense spending, advancement in domestic commercial aviation and development of the low-altitude economy are major potential drivers.

Hanmi Pharm (128940 KS): Corporate Value Enhancement Plan Targets W5 Trillion Revenue by 2033

By Tina Banerjee

Hanmi Pharm (128940 KS) targets revenue CAGR of at least 15% during 2025–2027 (2021–24: 7.5%) to achieve revenue of KRW2.3T in 2027 and KRW5T by 2033.
Hanmi expects to achieve operating profit of KRW380B in 2027, with operating margin of 16.5% (2024:14.4%). Operating profit is expected to reach KRW1T in 2033, with operating margin of 20.0%.
R&D pipeline should play a major role in achieving the targets. The company plans to gradually increase the R&D spending to 15%+ of revenue.

Multi Bintang Indonesia (MLBI IJ): Steady FY24, 9% Yield and >80% ROCE

By Sameer Taneja

Multi Bintang Indonesia (MLBI IJ) delivered steady FY24 growth, with revenue and profits up 1.9% and 7.1% YoY, respectively. Q4 FY24, however, underperformed expectations with revenue/profits up 0.6%/1.7% YoY.
Although Q4 typically represents >30% of overall annual revenue/profits, being the strongest season, its performance was disappointing compared to the strong 21%/35% YoY revenue/profit growth seen in Q3 2024.
Multi Bintang Indonesia (MLBI IJ) represents tremendous value with a dividend yield of 9% (100% payout), ROEs exceeding 80%, and a cheap multiple of 11x FY24 PE.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief Event-Driven: The USTR’s New “Proposed Actions” For Section 301 Investigation on China’s Maritime/Shipping Sectors and more

By Smartkarma Daily Briefs | Daily Briefs, Event-Driven

In today’s briefing:

The USTR’s New “Proposed Actions” For Section 301 Investigation on China’s Maritime/Shipping Sectors
A/H Premium Tracker (To 7 Mar 2025): AH Premia Still Falling; Expect Curve Torsion or AH Widening
HK Connect SOUTHBOUND Flows (To 7 Mar 2025); Big Volumes, Big Net; Tech, Banks, and Telecoms
Merger Arb Mondays (10 Mar) – Seven & I, Naigai, ESR, Soundwill, OneConnect, Goldlion, PointsBet
Soundwill Holdings (878 HK): Founder’s Scheme At $8.50/Share
SSI Weekly Highlights: Liquidations, Mergers, and Strategic Developments in Biopharma
Weekly Update (IDT, RHLD, SNRE, SNDK)

The USTR’s New “Proposed Actions” For Section 301 Investigation on China’s Maritime/Shipping Sectors

The USTR issued a Section 301 report in January 2025. The report suggests China has tried to achieve dominance in global shipping, to the detriment of US commerce.
The report is flawed, in data (it somehow manages to make up data which is otherwise available from MARAD), analytics, and conclusions, but the Trump administration has run with it.
In February, the USTR announced “Proposed Actions” – fees for Chinese liners and international liners with Chinese ships, and restrictions on future exports. US users lose. And there are loopholes.

A/H Premium Tracker (To 7 Mar 2025): AH Premia Still Falling; Expect Curve Torsion or AH Widening

AH Premia continue to fall. Spread curve torsion reverses again with wide premia trades seeing Hs perform the best vs their As.
To me, warning signs are flashing on spreads. They are at their narrowest in 5yrs and they are volatile. Last week I recommended a HUGE trimming (30%) of the book.
Hindsight is 20:20. I should have kept them, but the book still produced 51bp of alpha for the week on top of the 35bp of H/A beta.

HK Connect SOUTHBOUND Flows (To 7 Mar 2025); Big Volumes, Big Net; Tech, Banks, and Telecoms

By Special Situation Investments

Gross SOUTHBOUND volumes dropped somewhat but still high. NET buying by SOUTHBOUND was HK$35bn which is still quite strong. Round-tripping volume down 20% week-on-week.
The flows here are still striking. >20% of the top 100 most liquid Southbound eligible stocks saw SOUTHBOUND buy more than 10% of weekly volume.
It feels like there is some common understanding among SOUTHBOUND investors which I do not understand. The numbers are big/growing.

Merger Arb Mondays (10 Mar) – Seven & I, Naigai, ESR, Soundwill, OneConnect, Goldlion, PointsBet

By Arun George

We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Philippines, Thailand and Chinese ADRs.
Highest spreads: Naigai Trans Line (9384 JP), Soundwill Holdings (878 HK), Seven & I Holdings (3382 JP), OneConnect Financial Technology (OCFT US), Smart Share Global (EM US).
Lowest spreads: Shibaura Electronics (6957 JP), Domain Holdings Australia (DHG AU), PointsBet Holdings (PBH AU), Makino Milling Machine Co (6135 JP), Proto Corp (4298 JP).

Soundwill Holdings (878 HK): Founder’s Scheme At $8.50/Share

By David Blennerhassett

After small-cap property developer Soundwill Holdings (878 HK) was suspended pursuant to the Takeovers Code, I expected an Offer by way of Scheme.
And that is what unfolded. Grace Foo (ED) and her family, controlling 74.97% of shares out, are Offering $8.50/share, including a $1.00/share dividend, a 62.84% premium to undisturbed.
That’s still a whopping 87.66% discount to the most recent NAV (30th June 2024). But what are the options for minorities (apart from the headcount test)? And terms are final.

SSI Weekly Highlights: Liquidations, Mergers, and Strategic Developments in Biopharma

Abrdn Diversified Income And Growth is undergoing a wind-down, trading at a 30% discount to NAV, with potential liquidation acceleration.
OCI N.V.’s methanol business sale to Methanex is pending regulatory approvals, with unresolved Natgasoline JV stake issues affecting transaction value.
Pacific Current Group’s A$300m buyback tender extended, with shares trading below tender price, and potential further capital returns.

Weekly Update (IDT, RHLD, SNRE, SNDK)

By Richard Howe

There were no new spin-off announcements this week.
The Middleby Corporation (MIDD) announced its plan to spin off its food processing business on February 25, 2025.
This strategic move aims to allow Middleby to concentrate on its core commercial foodservice and residential kitchen equipment sectors, while enabling the new entity to focus exclusively on food processing operations.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief Macro: Tops Are Processes and more

By Smartkarma Daily Briefs | Daily Briefs, Macro

In today’s briefing:

Tops Are Processes
High Drama at the 200 Dma

Tops Are Processes

By Cam Hui

A review of the market’s technical conditions and macro backdrop is supportive of a long-term stock market top.
The good news is, in the absence of an active policy to engineer a slowdown, there is no recession in sight.
Our base case calls for an adjustment of growth expectations and a garden-variety bear market, which typically sees a drawdown of 20–30%.

High Drama at the 200 Dma

By Cam Hui

The S&P 500 fell last week to test support at the 200 dma.
Many elements of a tactical bottom are there, but not all.
Cutting through all the news-driven noise, we believe the stock market is poised for a relief rally, though it may be in need of a final sentiment flush.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Most Read: Japan Post Bank, Nikkei 225, A2 Milk Co Ltd, Sigma Healthcare, SK Innovation, Mitsui O.S.K. Lines, Daihatsu Diesel Mfg, DoorDash , China Vanke (H) and more

By Smartkarma Daily Briefs | Daily Briefs, Most Read

In today’s briefing:

Japan Post Bank (7182 JP) – Not Cheap Enough Vs Others, or Holdings
Index Rebalance Strategy YTD Performance: Not Many Places to Hide in Asia
S&P/NZX 10 Index Rebalance: A2 Milk (ATM NZ) Replaces Ryman Healthcare (RYM NZ)
S&P/ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices
Quiddity ASX Mar25 Results: Multiple Surprises; High Short Buildup for DELs; Rare Successful Trade
Got the BBIG Rebalancing Results: SK Innovation Is the Trade This Week
The USTR’s New “Proposed Actions” For Section 301 Investigation on China’s Maritime/Shipping Sectors
Daihatsu Diesel (6023) Buyback Tender Results Signal Overhang and Opportunity
S&P500/400/600 Index Rebalance: DASH In as Stability Trumps Volatility
A/H Premium Tracker (To 7 Mar 2025): AH Premia Still Falling; Expect Curve Torsion or AH Widening

Japan Post Bank (7182 JP) – Not Cheap Enough Vs Others, or Holdings

The Offering of Japan Post Bank (7182 JP) is not taking place the way “the right pattern” would suggest, but last time was kind of special. This time is different.
Last time was a “second IPO” and coincided with a US regional bank crisis. This time the offering is smaller outright, and much smaller as a portion of float.
Pricing is Monday. It hasn’t moved much vs JPH. It needs to move more to be attractive. And there is still a bit of overhang to come.

Index Rebalance Strategy YTD Performance: Not Many Places to Hide in Asia

We look at the performance of the index rebalance strategy over the year using weekly forecasts. In short, it has been a mixed bag for Asia.
India and China have been among the worst performing markets in the region while Australia and Korea have been among the better performers.
A lot of the outperformance appears to be front loaded, so getting the forecasts right early in the review period is of paramount importance.

S&P/NZX 10 Index Rebalance: A2 Milk (ATM NZ) Replaces Ryman Healthcare (RYM NZ)

A2 Milk Co Ltd (ATM NZ) will replace Ryman Healthcare (RYM NZ) in the S&P/NZX 10 Index at the close of trading on 21 March.
Passive trackers will need to buy 0.8x ADV in A2 Milk Co Ltd (ATM NZ) and will need to sell 1.2x ADV in Ryman Healthcare (RYM NZ).
Importantly, A2 Milk Co Ltd (ATM NZ) is a deletion from a global index at the close on 21 March and the selling from those passive trackers is far larger.

S&P/ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices

There are 2 changes for the S&P/ASX50 Index, 2 changes for the S&P/ASX100 Index, 7 changes for the S&P/ASX200 Index and 11 adds/ 7 deletes for the S&P/ASX300 Index.
There is a huge increase in the number of index shares for Sigma Healthcare (SIG AU), triggering passive buying of nearly A$1.4bn at the close on 21 March.
The adds have outperformed the deletes across all indices. Positioning varies across stocks and there could be some big movers over the next few days.

Quiddity ASX Mar25 Results: Multiple Surprises; High Short Buildup for DELs; Rare Successful Trade

By Janaghan Jeyakumar, CFA

The ADDs/DELs for the ASX index family for the March 2025 index rebal event were announced after market close on Friday 7th March 2025.
There are 22 ADDs and 18 DELs collectively for ASX 50, ASX 100, ASX 200, and ASX 300.
In this insight, we take a final look at the flow expectations for each of these index changes.

Got the BBIG Rebalancing Results: SK Innovation Is the Trade This Week

By Sanghyun Park

Real alpha? Tight basket means outsized passive flows. The play? SK Innovation, no contest.
Samsung SDI faces -0.54x ADTV outflows. Other movers: Netmarble 0.68x, Wemade Max 0.54x, NHN -0.46x ADTV.
Net-Net? SK Innovation is the trade. Long here, hedge short on Samsung SDI or the broader Battery space.

The USTR’s New “Proposed Actions” For Section 301 Investigation on China’s Maritime/Shipping Sectors

The USTR issued a Section 301 report in January 2025. The report suggests China has tried to achieve dominance in global shipping, to the detriment of US commerce.
The report is flawed, in data (it somehow manages to make up data which is otherwise available from MARAD), analytics, and conclusions, but the Trump administration has run with it.
In February, the USTR announced “Proposed Actions” – fees for Chinese liners and international liners with Chinese ships, and restrictions on future exports. US users lose. And there are loopholes.

Daihatsu Diesel (6023) Buyback Tender Results Signal Overhang and Opportunity

In late January, Daihatsu Diesel Mfg (6023 JP) announced its once/former parent would sell all its shares; in part to a private company in the industry and a 20% buyback.
The buyback – a below-market own-share tender offer – was priced low enough to be a big win. Accretion added to that.
Buyback Tender Results and External Changes signal overhang and opportunity. Either way, it’s cheap, but good governance could make it even cheaper.

S&P500/400/600 Index Rebalance: DASH In as Stability Trumps Volatility

There are 4 changes for the S&P 500 INDEX, 6 changes for the S&P Midcap400 Index and 14 changes for the S&P SmallCap600 Index at the March rebalance.
DoorDash (DASH US) was newly eligible after meeting the profitability criterion, while AppLovin (APP US), Coinbase Global (COIN US) and Interactive Brokers Group, Inc (IBKR US) were overlooked again.
There will be more same-way flow for the S&P 500 INDEX (SPX INDEX) adds and deletes from the Select Sector index trackers.

A/H Premium Tracker (To 7 Mar 2025): AH Premia Still Falling; Expect Curve Torsion or AH Widening

AH Premia continue to fall. Spread curve torsion reverses again with wide premia trades seeing Hs perform the best vs their As.
To me, warning signs are flashing on spreads. They are at their narrowest in 5yrs and they are volatile. Last week I recommended a HUGE trimming (30%) of the book.
Hindsight is 20:20. I should have kept them, but the book still produced 51bp of alpha for the week on top of the 35bp of H/A beta.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Analytics and News
✓ Events & Webinars

Mar 10

Daily Brief South Korea: SK Innovation, Korea Stock Exchange KOSPI 200, Hanmi Pharm and more

By Smartkarma Daily Briefs | Daily Briefs, South Korea

In today’s briefing:

Got the BBIG Rebalancing Results: SK Innovation Is the Trade This Week
The Week Ahead in Options – 10 March
Kospi Index Options Weekly (Mar 04 – 07): Market Stabilizes After Sharp Drop
Hanmi Pharm (128940 KS): Corporate Value Enhancement Plan Targets W5 Trillion Revenue by 2033

Got the BBIG Rebalancing Results: SK Innovation Is the Trade This Week

By Sanghyun Park

Real alpha? Tight basket means outsized passive flows. The play? SK Innovation, no contest.
Samsung SDI faces -0.54x ADTV outflows. Other movers: Netmarble 0.68x, Wemade Max 0.54x, NHN -0.46x ADTV.
Net-Net? SK Innovation is the trade. Long here, hedge short on Samsung SDI or the broader Battery space.

The Week Ahead in Options – 10 March

By Gaudenz Schneider

US steel and aluminum tariffs (effective 12 March US time) will take effect on March 13 across the Asia-Pacific region. Volatility can be expected in Japan, South Korea, India, China.
Major quarterly derivatives expirations will occur on March 13 in Japan (Nikkei 225, TOPIX, Stocks), South Korea (KOSPI 200, KOSDAQ 150, Stocks), and India (BSE Stock Futures and Options).
Earnings announcements for AIA Group (1299 HK) and Li Auto (2015 HK/LI US) are scheduled for March 14, while India’s markets will be closed that day for the Holi holiday.

Kospi Index Options Weekly (Mar 04 – 07): Market Stabilizes After Sharp Drop

By John Ley

Kospi takes a breather this week after last Friday’s sell-off to trade in a narrow range.
Short-Term volatility eases in trade shortened week pulling implied vol down.
We highlight the dynamic between implied and historic volatility and discuss whether long or short volatility strategies have been the most effective this year.

Hanmi Pharm (128940 KS): Corporate Value Enhancement Plan Targets W5 Trillion Revenue by 2033

By Tina Banerjee

Hanmi Pharm (128940 KS) targets revenue CAGR of at least 15% during 2025–2027 (2021–24: 7.5%) to achieve revenue of KRW2.3T in 2027 and KRW5T by 2033.
Hanmi expects to achieve operating profit of KRW380B in 2027, with operating margin of 16.5% (2024:14.4%). Operating profit is expected to reach KRW1T in 2033, with operating margin of 20.0%.
R&D pipeline should play a major role in achieving the targets. The company plans to gradually increase the R&D spending to 15%+ of revenue.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Mar 10

Daily Brief Australia: Sigma Healthcare and more

By Smartkarma Daily Briefs | Australia, Daily Briefs

In today’s briefing:

S&P/ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices
Quiddity ASX Mar25 Results: Multiple Surprises; High Short Buildup for DELs; Rare Successful Trade

S&P/ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices